News and Announcements
Shivom: Kickstarting 2019 with a splendid vision
- Published January 08, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- 2018 was a successful year for Shivom as they launched the Alpha version of their product.
- The company featured on CNBC Advancements’.
- Henry Ines, Shivom’s CEO, appeared on NASDAQ’s Innovators segment hosted by Jane King.
2018 was a successful year for Shivom as they launched the Alpha version of their product and actively engaged in several key partnerships. At the end of 2018, Shivom featured in CNBC Advanvements’ segment, hosted by Ted Danson. Advancements is an educational series dedicated to informing the public about the latest innovations taking place today. Advancements explores the significant issues impacting society and aim to uncover the best kept secrets to raise social awareness. The segment focused on new technologies such as blockchain, cryptocurrency and AI. Shivom was pleased to feature on the segment alongside other startups such as Bethereum, Paytomat and ETouchMenu. This year, Shivom’s CEO appeared on NASDAQ’s innovators hosted by Jane King. He discussed the future of precision medicine and product updates.
Recently, Shivom has been widely featured across CNBC, CNBC Africa, Kron 4 (San Francisco Bay Area), Fox Business News and Bloomberg. A 12-part interview series with Nasdaq will also widespread their mission globally.
Upcoming Events for Shivom
- Blockchain Connect Conference @ San Francisco Marriott Marquis – January 11
- Precision Medicine World Conference 2018 @ Santa Clara Convention Center, Silicon Valley, USA – January 21 – 23
- Blockchain Applications for Pharma @ Hyperion Hotel, Basel, Switzerland – January 23 – 24
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
